Source: Eur Respir J 2001; 17: 628-635
Disease area: Interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Baculard A., Blanc N., Boule M., Fauroux B., Chadelat K., Boccon-Gibod L., Tournier G., Clement A.. Pulmonary sarcoidosis in children: a follow-up study. Eur Respir J 2001; 17: 628-635

Member's Comments

No comment yet.

Related content which might interest you: Relationship between radiologic patterns, pulmonary function values and BALF cells in newly diagnosed sarcoidosis Source: International Congress 2015 – Sarcoidosis: clinical Year: 2015 Relationship between Ca19.9 levels in bronchoalveolar lavage, neutrophilic alveolitis, pulmonary function tests and HRCT pattern in pulmonary fibrosis Source: Eur Respir J 2003; 22: Suppl. 45, 588s Year: 2003 Retrospective assessment of pulmonary sarcoidosis with the aid of bronchoalveolar lavage (BAL) during the past three-year period in a general hospital Source: Annual Congress 2013 –Sarcoidosis and other granulomatosis Year: 2013 Pulmonary and systemic inflammation in patients with AECOPD Source: Annual Congress 2013 –COPD: new markers of diseases Year: 2013 Long-term durable benefit after whole lung lavage in pulmonary alveolar proteinosis Source: Eur Respir J 2004; 23: 526-531 Year: 2004 Cellular composition of bronchoalveolar lavage (BAL) as inflammation indicator in patients with chronic obstructive pulmonary disease (COPD) Source: International Congress 2014 – Diagnostic and therapeutic bronchoscopy: old and new techniques for interventional pulmonology Year: 2014 Bronchoalveolar lavage Source: Eur Respir Mon; 2010: 48: 59–72 Year: 2010 Is the severity of newly diagnosed pulmonary sarcoidosis reflected by bronchoalveolar lavage (BAL) parameters? Source: Eur Respir J 2002; 20: Suppl. 38, 468s Year: 2002 Is the severity of newly diagnosed pulmonary sarcoidosis reflected by bronchoalveolar lavage (BAL) parameters? Source: Eur Respir J 2001; 18: Suppl. 33, 507s Year: 2001 Clinical and immunological parameters in patients with newly diagnosed sarcoidosis Source: Annual Congress 2013 –Diffuse parenchymal lung disease III Year: 2013 Airway wall eosinophilia in severe asthmatic children: predictive values for noninvasive tests Source: Annual Congress 2006 - Markers of paediatric airway disease Year: 2006 The role of the combined assessment of the bronchoalveolar lavage (BAL) and radiological profile in the diagnosis of chronic eosinophilic pneumonia (CEP) Source: Annual Congress 2013 –Modern approach to various clinical settings Year: 2013 Sampling the lung fluids: peripheral biomarkers Source: Annual Congress 2007 - Pulmonary biomarkers in COPD Year: 2007 Changes of BAL findings as no progression marker in idiopathic pulmonary fibrosis (IPF) patients treated with IFN-g Source: Annual Congress 2006 - Usefulness of broncoalveolar lavage (BAL) in interstitial lung diseases Year: 2006 Bronchoalveolar lavage (BAL) as a diagnostic tool in pulmonary hypertension: occult alveolar haemorrhage is a common feature of pulmonary veno-occlusive disease (PVOD) Source: Annual Congress 2003 - Pulmonary hypertension Year: 2003 Long term follow up of the whole lung lavage programme in patients with pulmonary alveolar proteinosis: an update Source: Annual Congress 2006 - Usefulness of broncoalveolar lavage (BAL) in interstitial lung diseases Year: 2006 Lysozyme level and activity are decreased in the lungs of patients with idiopathic pulmonary fibrosis (IPF) and potentially contribute to increased susceptibility to pulmonary infection Source: Annual Congress 2006 - Usefulness of broncoalveolar lavage (BAL) in interstitial lung diseases Year: 2006 Calgranuline B in bronchoalveolar lavage of patients with idiopathic pulmonary fibrosis Source: Annual Congress 2009 - What is new in molecular pathology and functional genomics of neoplastic and non-neoplastic lung disease? Year: 2009